Clinical Trials Logo

Filter by:
NCT ID: NCT04818489 Active, not recruiting - Covid19 Clinical Trials

Colchicine and Post-COVID-19 Pulmonary Fibrosis

Start date: March 25, 2021
Phase: Phase 4
Study type: Interventional

Pulmonary fibrosis is a sequela to adult respiratory distress syndrome (ARDS). 40% of patients with corona virus disease 2019 (COVID-19) develop ARDS, and 20% of them are severe. Clinical, radiographic, and autopsy reports of pulmonary fibrosis were commonplace following SARS and MERS, and current evidence suggests pulmonary fibrosis could complicate infection by SARS-CoV-2 too. Colchicine has a direct anti-inflammatory effect by inhibiting the synthesis of tumor necrosis factor alpha and IL-6, monocyte migration, and the secretion of matrix metalloproteinase-9. It suppress secretion of cytokines and chemokines as well as in vitro platelet aggregation. All these are potentially beneficial effects that might diminish the COVID-19 inflammatory storm associated with severe cases.

NCT ID: NCT04811911 Active, not recruiting - Psoriasis Clinical Trials

Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis

Start date: December 13, 2020
Phase: Phase 4
Study type: Interventional

The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum TWEAK level in psoriatic patients.

NCT ID: NCT04811326 Active, not recruiting - Clinical trials for Non-segmental Vitiligo

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

Start date: January 13, 2021
Phase: Phase 4
Study type: Interventional

The aim of the study is to evaluate the efficacy of different lines of therapies on the TWEAK serum level in patients with non-segmental vitiligo.

NCT ID: NCT04800445 Active, not recruiting - Neonatal Sepsis Clinical Trials

Salivary C- Reactive Protein, Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis

Start date: April 4, 2020
Phase:
Study type: Observational

To evaluate reliability of salivary C-reactive protein ,mean platelet volume , neutrophil -lymphocyte ratio , and platelet lymphocyte ratio in diagnosis of neonatal sepsis

NCT ID: NCT04796376 Active, not recruiting - High Anal Fistula Clinical Trials

The Outcome of Combined Partial Fistulectomy or Fistulotomy and Cutting Seton Procedure in High Perianal Fistula

Start date: October 10, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to assess the effectiveness and suitability of the tight (cutting) seton as a surgical treatment of high anal fistula combined with partial fistulotomy or fistulectomy in a prospective study.

NCT ID: NCT04789837 Active, not recruiting - Osteoarthritis Clinical Trials

The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis

Start date: March 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Cilostazol is able to suppress the degradation of type II collagen in human chondrocytes induced by IL-1b. Cilostazol add-on for celecoxib therapy has synergistic anti-arthritic potential by inhibiting proinflammatory cytokine production in synovial fibroblasts through the IL-10/SOCS3 pathways, consequently leading to the inhibition of synovial cell proliferation and overcoming the perpetuation of synovial inflammation.

NCT ID: NCT04780412 Active, not recruiting - Clinical trials for Neonatal Respiratory Distress

Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section

Start date: September 1, 2020
Phase: Phase 3
Study type: Interventional

Neonatal respiratory morbidities represent a common group of post natal complications including respiratory distress syndrome, transient tachypnea of newborn, and persistent pulmonary hypertension of newborn. It is thought that preoperative vaginal misoprostol administration may decrease the incidence of neonatal respiratory morbidity especially transient tachypnea of newborn. And therefore, it may decrease the incidence of admission to neonatal intensive care units for respiratory causes.

NCT ID: NCT04776369 Active, not recruiting - Postoperative Pain Clinical Trials

Effect of Lidocaine Versus Magnesium on Postoperative Pain in Spine Surgery

Start date: May 1, 2022
Phase: Phase 4
Study type: Interventional

The goal in this work is to compare the effect of intravenous single-bolus lidocaine infusion versus intravenous single-bolus magnesium sulfate infusion on postoperative pain, emotional status and quality of life in patients undergoing spine fusion surgery.

NCT ID: NCT04772846 Active, not recruiting - Glioblastoma Clinical Trials

Chloroquine for Glioblastoma.

Start date: March 1, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Adjuvant chloroquine to the conventional treatment for glioblastoma; A randomized, single-blind, placebo-controlled, phase I/II trial.

NCT ID: NCT04770896 Active, not recruiting - Clinical trials for Unresectable Hepatocellular Carcinoma

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab

IMbrave251
Start date: April 26, 2021
Phase: Phase 3
Study type: Interventional

This is a Phase III, open-label, multicenter, randomized, two-arm study designed to evaluate the efficacy and safety of atezolizumab plus either lenvatinib or sorafenib versus lenvatinib or sorafenib alone in participants with locally advanced or metastatic Hepatocellular Carcinoma (HCC) who have progressed on prior systemic treatment with atezolizumab plus bevacizumab combination.